[go: up one dir, main page]

BG102667A - Състав, съдържащ диосгенин - Google Patents

Състав, съдържащ диосгенин

Info

Publication number
BG102667A
BG102667A BG102667A BG10266798A BG102667A BG 102667 A BG102667 A BG 102667A BG 102667 A BG102667 A BG 102667A BG 10266798 A BG10266798 A BG 10266798A BG 102667 A BG102667 A BG 102667A
Authority
BG
Bulgaria
Prior art keywords
diosgenine
containing composition
ofosteoporosis
effectivequantities
vitaminb6
Prior art date
Application number
BG102667A
Other languages
English (en)
Inventor
Paul Clayton
Original Assignee
The Boots Company Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Boots Company Plc filed Critical The Boots Company Plc
Publication of BG102667A publication Critical patent/BG102667A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретението се отнася до профилактика или лечение на остеопороза чрез прилагане на лечебноефективни количества диосгенин и витамини К и D, в даден случай витамини В6 и/или А.
BG102667A 1996-01-12 1998-08-04 Състав, съдържащ диосгенин BG102667A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9600604.4A GB9600604D0 (en) 1996-01-12 1996-01-12 Composition
PCT/EP1997/000166 WO1997025049A1 (en) 1996-01-12 1997-01-10 Composition containing diosgenin

Publications (1)

Publication Number Publication Date
BG102667A true BG102667A (bg) 1999-02-26

Family

ID=10786934

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102667A BG102667A (bg) 1996-01-12 1998-08-04 Състав, съдържащ диосгенин

Country Status (18)

Country Link
US (1) US5968917A (bg)
EP (1) EP0873125A1 (bg)
JP (1) JP2000503020A (bg)
KR (1) KR19990077143A (bg)
CN (1) CN1208351A (bg)
AU (1) AU703311B2 (bg)
BG (1) BG102667A (bg)
CA (1) CA2242589A1 (bg)
CZ (1) CZ219798A3 (bg)
GB (1) GB9600604D0 (bg)
HU (1) HUP9900978A3 (bg)
IL (1) IL125313A0 (bg)
NO (1) NO983184L (bg)
NZ (1) NZ326345A (bg)
PL (1) PL327833A1 (bg)
SK (1) SK94298A3 (bg)
WO (1) WO1997025049A1 (bg)
ZA (1) ZA97252B (bg)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9713620D0 (en) * 1997-06-28 1997-09-03 Boots Co Plc Composition
EP1379146B1 (en) * 2001-03-23 2009-04-29 N.V. Nutricia Preparation for the prevention and/or treatment of altered bone metabolism
US20050090457A1 (en) * 2002-02-15 2005-04-28 N.V. Nutricia Method of treating mammals with genistein and/or genistein analogues
GB0220182D0 (en) * 2002-08-30 2002-10-09 Cardiovascular Res Inst Maastr Organic compounds
US20040162292A1 (en) * 2002-12-03 2004-08-19 Evenstad Kenneth L. Multivitamin formulations for promoting healthy collagen, and methods of their use
US20060068036A1 (en) * 2002-12-31 2006-03-30 National Yang-Ming University Extract of Dioscorea sp. and the medical uses thereof
US8668908B2 (en) * 2002-12-31 2014-03-11 National Yang-Ming University Method for alleviating chemotherapy side effects using extract of Dioscorea sp
US20040126447A1 (en) * 2002-12-31 2004-07-01 Rong-Tsun Wu Extract of Dioscorea sp. and the medical uses thereof
AU2004202986B2 (en) * 2004-06-30 2006-09-07 National Yang-Ming University An extract of dioscorea sp. and the medical uses thereof
TWI422378B (zh) * 2010-11-18 2014-01-11 Univ Chung Shan Medical 使用薯蕷皂素來改善與停經期症候群有關聯的認知缺陷
KR101480982B1 (ko) * 2013-03-20 2015-02-03 (주)셀인바이오 골형성 유도 화합물 및 이의 응용
CN103142640A (zh) * 2013-04-01 2013-06-12 李拖平 含有维生素k2的具有预防与治疗骨质疏松症的保健品

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05238929A (ja) * 1992-02-27 1993-09-17 Sumitomo Pharmaceut Co Ltd 代謝性骨疾患治療用長期持続性製剤

Also Published As

Publication number Publication date
CZ219798A3 (cs) 1999-02-17
PL327833A1 (en) 1999-01-04
HUP9900978A3 (en) 2001-04-28
HUP9900978A2 (hu) 1999-09-28
CN1208351A (zh) 1999-02-17
GB9600604D0 (en) 1996-03-13
KR19990077143A (ko) 1999-10-25
SK94298A3 (en) 1999-01-11
JP2000503020A (ja) 2000-03-14
US5968917A (en) 1999-10-19
EP0873125A1 (en) 1998-10-28
ZA97252B (en) 1997-10-23
NZ326345A (en) 2000-12-22
NO983184L (no) 1998-07-10
AU1442697A (en) 1997-08-01
AU703311B2 (en) 1999-03-25
IL125313A0 (en) 1999-03-12
WO1997025049A1 (en) 1997-07-17
CA2242589A1 (en) 1997-07-17

Similar Documents

Publication Publication Date Title
GR3026758T3 (en) Lactobacillus strains of human origin, their compositions and uses thereof
BG107537A (bg) Инхибиране на човешка tnf алфа активност
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
HK1027280A1 (en) Plant extracts for the treatment of increased boneresorption.
BG100960A (bg) Дозирани форми с контролирано освобождаване на азитромицин
MD1745B2 (en) 4,5-dimethyl-N-2-propenyl-2-(trimethylsilyl)-3-thiophencarboxamide, fungicidal composition on base thereof and method of plants diseases control
BG102999A (bg) Нови 2,3 дизаместени-4(3н)-хиназолинони
EP0626174A3 (en) Method and composition for the prophylaxis and / or treatment of underactive organs.
IL110943A (en) Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
HUP9903166A3 (en) Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
EP0596962A4 (en) Therapeutic compositions and methods.
BG102250A (bg) Използване на гликозиди, извлечени от невен, за лечение на псориаза
BG102667A (bg) Състав, съдържащ диосгенин
AU4830097A (en) Use of an extract of Cimicifuga
EP0612513A3 (en) External skin treatment composition.
BG104179A (bg) Използване на фанхинон за лечението на болестта на алцхаймер
AU2807492A (en) Use of misoprostol for the treatment of allergy
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
BG102707A (bg) Нови триазолопурини, метод за тяхното получаване и тяхното приложение като лекарствени средства
BG102716A (bg) Метод за лекуване на сърдечна недостатъчност със средства противодействащи на ендотелина
IL116826A (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for treatment or prophylaxis of obesity
WO1992021655A3 (en) 2-methyl-5-hydroxymethyl- and 2,5-dimethyl-3,4-dihydroxypyrrolidines
UA29461C2 (uk) Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу
ZA971036B (en) Pharmaceutical compositions for the prevention or treatment of retrovirus infections.
MY127662A (en) Compositions, comprising bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders